Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.

Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E, Jouary T, Longy M, Vergier B, Beylot-Barry M, Merlio JP.

J Invest Dermatol. 2010 Jun;130(6):1707-18. doi: 10.1038/jid.2010.8. Epub 2010 Feb 4.

2.

Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.

Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ.

Br J Dermatol. 2002 Sep;147(3):464-75.

PMID:
12207585
3.

Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.

Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

J Invest Dermatol. 2006 Jun;126(6):1388-95.

4.

BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

Br J Dermatol. 2004 Sep;151(3):546-56.

PMID:
15377339
5.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. Review.

PMID:
24438969
6.

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.

Br J Dermatol. 2006 Oct;155(4):756-62.

PMID:
16965425
7.

Clinicopathological characterization and genomic aberrations in subcutaneous panniculitis-like T-cell lymphoma.

Hahtola S, Burghart E, Jeskanen L, Karenko L, Abdel-Rahman WM, Polzer B, Kajanti M, Peltomäki P, Pettersson T, Klein CA, Ranki A.

J Invest Dermatol. 2008 Sep;128(9):2304-9. doi: 10.1038/jid.2008.6. Epub 2008 Mar 13.

8.

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ.

Blood. 2003 Feb 15;101(4):1513-9. Epub 2002 Oct 3.

9.

CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.

Laharanne E, Chevret E, Idrissi Y, Gentil C, Longy M, Ferrer J, Dubus P, Jouary T, Vergier B, Beylot-Barry M, Merlio JP.

Mod Pathol. 2010 Apr;23(4):547-58. doi: 10.1038/modpathol.2009.196. Epub 2010 Jan 29.

10.

IRF4 gene rearrangements define a subgroup of CD30-positive cutaneous T-cell lymphoma: a study of 54 cases.

Pham-Ledard A, Prochazkova-Carlotti M, Laharanne E, Vergier B, Jouary T, Beylot-Barry M, Merlio JP.

J Invest Dermatol. 2010 Mar;130(3):816-25. doi: 10.1038/jid.2009.314. Epub 2009 Oct 8.

11.

Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.

Bosisio FM, Cerroni L.

Am J Dermatopathol. 2015 Feb;37(2):115-21. doi: 10.1097/DAD.0000000000000258.

PMID:
25406852
12.

Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.

Chevret E, Andrique L, Prochazkova-Carlotti M, Ferrer J, Cappellen D, Laharanne E, Idrissi Y, Boettiger A, Sahraoui W, Ruiz F, Pham-Ledard A, Vergier B, Belloc F, Dubus P, Beylot-Barry M, Merlio JP.

Blood. 2014 Mar 20;123(12):1850-9. doi: 10.1182/blood-2013-05-500686. Epub 2014 Jan 27.

13.

[Rare variants of cutaneous T-cell lymphomas].

Goerdt S, Trautmann C, Kütting B, Ramaker J, Schmuth M, Thiel E, Luger T, Stein H, Orfanos CE.

Hautarzt. 1996 Feb;47(2):96-105. Review. German.

PMID:
8868452
14.

Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).

Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P, et al.

J Invest Dermatol. 1994 Jul;103(1):34-41.

15.

Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.

Poenitz N, Simon-Ackermann J, Gratchev A, Qadoumi M, Klemke CD, Stadler R, Kremer A, Radenhausen M, Henke U, Assaf C, Utikal J, Goerdt S, Dippel E.

Dermatology. 2005;211(2):84-92.

PMID:
16088151
16.

Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.

Klemke CD, Fritzsching B, Franz B, Kleinmann EV, Oberle N, Poenitz N, Sykora J, Banham AH, Roncador G, Kuhn A, Goerdt S, Krammer PH, Suri-Payer E.

Leukemia. 2006 Jun;20(6):1123-9.

PMID:
16557241
17.

TOX expression in different subtypes of cutaneous lymphoma.

Morimura S, Sugaya M, Suga H, Miyagaki T, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.

Arch Dermatol Res. 2014 Nov;306(9):843-9. doi: 10.1007/s00403-014-1501-7. Epub 2014 Sep 13.

PMID:
25216799
18.

Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.

Hahtola S, Tuomela S, Elo L, Häkkinen T, Karenko L, Nedoszytko B, Heikkilä H, Saarialho-Kere U, Roszkiewicz J, Aittokallio T, Lahesmaa R, Ranki A.

Clin Cancer Res. 2006 Aug 15;12(16):4812-21.

19.

Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.

Fivenson DP, Hanson CA, Nickoloff BJ.

J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):717-23.

PMID:
7929915
20.

Mycosis fungoides and Sézary syndrome.

Espinet B, Salgado R.

Methods Mol Biol. 2013;973:175-88. doi: 10.1007/978-1-62703-281-0_11.

PMID:
23412790
Items per page

Supplemental Content

Write to the Help Desk